iPLEDGE Login: Official Site and What Patients Do Next

Quick answer: The official iPLEDGE site is ipledgeprogram.com, and its top menu has an “Enroll | Login” link. According to the Accutane® label, patients who can become pregnant must use the iPLEDGE system by internet or telephone. They do so before starting isotretinoin, monthly during treatment, and one month after the last dose. The iPLEDGE site lists a toll-free number for questions, 1-866-495-0654, as checked on October 12, 2026. Its patient troubleshooting sheet points to the “Forgot Username?” and “Forgot password?” links on the site. FDA-approved changes are planned for November 15, 2026 and are not in effect today.

This page covers where the login lives, what patients do after logging in, the timing windows for each patient group, and what to do when access fails. It also separates the rules in force today from the changes planned for November 15, 2026. Facts come from the iPLEDGE site, the FDA, the Accutane® label and MedlinePlus, and we say when we checked each live page.

Where is the official iPLEDGE login?

The program’s own site is ipledgeprogram.com. The Accutane® label and its Medication Guide give the same address. The FDA’s iPLEDGE REMS page describes iPLEDGE as a shared system that includes all FDA-approved isotretinoin products. On October 12, 2026, the home page showed “Enroll | Login” in its top menu, with separate pages for prescribers, designees, pharmacies and patients.

The Medication Guide in the label gives the same two ways to reach the program: the website and the phone line. For the login itself, the program’s own patient tips sheet is the official guide, and the section on lost passwords below quotes it.

One more point from the site: its patient page says patients cannot enroll directly. A prescriber enrolls every patient, and the page tells anyone who believes they should be enrolled to contact their prescriber.

Which steps do patients complete in iPLEDGE?

The answer depends on the patient group. iPLEDGE sorts patients into two categories. The FDA page says that since December 13, 2021, each patient is assigned to one of them: patients who can get pregnant or patients who cannot. According to the label, only the first group has monthly patient steps in the system today.

Patients who can get pregnant

The Accutane® label says these patients must access the iPLEDGE system via the internet or telephone. They do so before starting isotretinoin, on a monthly basis during therapy, and one month after the last dose. At each of those points they answer questions on the program requirements and enter their two chosen forms of contraception.

MedlinePlus puts it this way: you contact iPLEDGE by phone or the internet every month. You confirm the two forms of birth control you are using and answer two questions about the program. You can keep getting isotretinoin only if you have done this and have visited your doctor to talk about how you are feeling and using birth control. You also need a negative pregnancy test within the past 7 days.

The same label says these patients need two negative pregnancy tests before the first prescription, with an interval of at least 19 days between them. The second test must be done in a CLIA-certified laboratory. The FDA says pre-treatment tests are completed in a medical setting, and our iPledge FAQ says that for a telehealth patient this means a lab.

Patients who cannot get pregnant

The label places the questions and the contraception entry under patients who can become pregnant. For patients who cannot, its monthly table lists the prescriber confirming counseling and the pharmacist contacting the system for an authorization. So the table lists no monthly iPLEDGE questions or forms for you to complete.

Your own step comes at the start. The label says all patients must sign a Patient Enrollment Form, and patients who cannot get pregnant sign the form written for their group. MedlinePlus adds that all patients, including men and women who cannot become pregnant, must be registered with iPLEDGE to get isotretinoin. Our article on iPledge program requirements lists the full set of conditions.

What are the timing windows for each patient group?

The window is the time you have to pick up a prescription. Its length and its start date differ by group, and the label gives both numbers.

The label says patients who can become pregnant must obtain the prescription within 7 days of the date of specimen collection for the pregnancy test. Patients who cannot become pregnant must obtain it within 30 days of the office visit.

As of October 12, 2026, those are the rules in force. The approved REMS document adds that the authorization for patients who can get pregnant is valid for 7 days from the date of the specimen collection. The same document says pharmacies do not dispense refills and limit each fill to a 30-day supply.

If a patient who can get pregnant misses the first 7-day window before treatment, today’s rules include a 19-day wait. The FDA’s page describes removing that “19-day lockout” in the approved changes, which are covered below. Our article on the missed prescription window explains what happens next for each group, and the one on prescription window timing lays out the day counts.

From running iPledge logistics, we know that a missed window does not generate a warning email from iPledge. Knowing your own start date and end date for each window is part of the job.

What if you are locked out or lost your password or ID?

The iPLEDGE site’s Troubleshooting Tips page links to a tips sheet for patients, dated April 2022 and checked October 12, 2026. It says to use the “Forgot Username?” link if you do not have your username, and the “Forgot password?” link to update your password. If no reset email arrives, the sheet says to confirm the email address is active and spelled correctly, then check your Spam/Junk folder. If it still does not arrive, your details may not match what iPLEDGE has on file, and the sheet says to contact the Contact Center. The site’s pages carry the line “Have Questions? Call our toll-free number 1-866-495-0654,” checked October 12, 2026.

The same number appears in the Accutane® Medication Guide, which says you can call iPLEDGE REMS at 1-866-495-0654 or visit the website. Pharmacists use that line too, because the label lists the website and that same phone number as ways to obtain authorization for every isotretinoin prescription.

If the problem is your identification number, MedlinePlus says your doctor gives you an identification number and card when treatment starts. You need the number to fill your prescriptions. Your prescriber’s office issued it, so that is where to ask about a lost one.

Skip any workarounds, because the label says isotretinoin must not be prescribed, dispensed or otherwise obtained through the internet or any other means outside the iPLEDGE REMS. Call the number early in your window rather than on the last day.

What will change on November 15, 2026 for patients?

The FDA approved changes to the iPLEDGE REMS on February 9, 2026. The agency first set August 8, 2026, then moved the planned implementation date to November 15, 2026. The iPLEDGE home page now carries a notice marked “Effective November 15, 2026.” As of October 12, 2026, none of what follows is in effect. Keep following the current rules until that date passes.

The iPLEDGE notice lists these changes for that date, among others.

• Pharmacists will no longer receive a “Do Not Dispense To Patient After Date” for patients who cannot get pregnant. The FDA’s description of the approved changes says there is no longer a 30-day prescription window for that group.
• The 19-day lockout will be removed. Before treatment starts, a repeat confirmatory test in a medical setting is required for a patient who can get pregnant and did not obtain isotretinoin in the first 7-day window. The repeat test has no waiting period.
• For patients who can get pregnant, the interval between the two pre-treatment tests is listed as at least 30 days, where today’s label says at least 19.
• Prescribers will document counseling in the system for patients who cannot get pregnant only at enrollment, not monthly.
• Only a prescriber can change a patient’s category.

The FDA page says prescribers must continue to complete pre-treatment pregnancy tests in a medical setting for patients who can get pregnant. Those tests stay there before and after that date.

Are home pregnancy tests allowed during and after treatment?

Yes, today, and that is not a November 15 change. The FDA page says the agency continues to exercise enforcement discretion on pregnancy testing until the modifications are fully implemented. Under its October 2023 update, the FDA does not intend to object if prescribers rely on patients who can get pregnant to perform home pregnancy tests. Those patients report the dates and results during and after isotretinoin treatment.

Three limits apply to home testing. All pre-treatment tests for patients who can get pregnant must still be performed in a medical setting. Prescribers remain responsible for interpreting and documenting results in iPLEDGE, and they must take steps to minimize falsified results. The Accutane® label still says the monthly test for patients who can become pregnant is done in a CLIA-certified laboratory. The FDA has said it does not intend to object to home tests under its October 2023 update. Your prescriber decides whether to allow a home test for you. The approved changes keep that option during and after treatment, so home testing is not a November 15 start.

Where does The Goal Is Clear fit?

The Goal Is Clear’s Accutane® FAQ says every Accutane® patient gets an iPledge Concierge who tracks monthly windows, pregnancy tests and refills. It adds that you get window-open alerts, refill reminders and a heads-up before the window closes. The iPledge FAQ says that every window-open and window-closing event triggers an alert.

The Concierge tracks your windows, tests and refills. Your own steps in iPLEDGE stay with you and your prescriber, and your board-certified dermatologist decides whether isotretinoin fits your case. A prescription is never guaranteed for any patient.

Medication is billed separately by the pharmacy, as low as $0 for the prescription with insurance. See the pricing page and the Accutane® cost FAQ for how billing works. For the wider picture, read our guides to the iPledge program and to iPLEDGE REMS.

Common questions about the iPLEDGE login

Where do I log in to iPLEDGE? The official site is ipledgeprogram.com, which has an “Enroll | Login” link in its top menu as of October 12, 2026.

Which steps come next once I am inside? If you can get pregnant, the label says you answer program questions and enter your two chosen forms of contraception. You do so before starting, monthly during treatment and one month after the last dose. If you cannot get pregnant, the label’s monthly table lists no patient step for you.

Which number reaches iPLEDGE when my access fails? The iPLEDGE site lists a toll-free number for questions, 1-866-495-0654, as checked October 12, 2026. The program’s patient tips sheet points to the “Forgot Username?” and “Forgot password?” links, and says to contact the Contact Center if no reset email arrives.

How long do I have to pick up my prescription? As of October 12, 2026, patients who can become pregnant have 7 days from the pregnancy test’s specimen collection date. Patients who cannot become pregnant have 30 days from the office visit, according to the label. The FDA’s description of the approved changes says the 30-day window for that group ends once they take effect, planned for November 15, 2026.

Can I use a home pregnancy test? Under the FDA’s October 2023 enforcement discretion, a prescriber may rely on home pregnancy tests during and after treatment for patients who can get pregnant. Pre-treatment tests for patients who can get pregnant stay in a medical setting, and your prescriber decides. Home testing does not end on November 15 either, because the approved changes let a prescriber permit tests outside a medical setting during and after treatment.

What should you do before your first month starts?

Write down your patient group, your window length and the iPLEDGE phone number before your first month starts. Then note when each window starts: the specimen collection date if you can get pregnant, the office visit date if you cannot, according to the label. If you are choosing a way to get care, the 2-minute quiz comes first, and a board-certified dermatologist reviews your case within 24 hours.

This article is general information, not medical advice. A prescription is never guaranteed, and treatment decisions stay with the board-certified dermatologist who reviews your case. Accutane® is a registered trademark of its respective owner, and isotretinoin is the generic name. The Goal Is Clear is operated by BNG Health Services, LLC, which is not the prescribing physician; board-certified dermatologists prescribe.

Sources

• iPLEDGE REMS official site, home and patient pages (checked October 12, 2026)
• iPLEDGE, Troubleshooting Tips for Patients (updated April 10, 2022; checked October 12, 2026)
• FDA, iPLEDGE Risk Evaluation and Mitigation Strategy (REMS)
• FDA, approved iPLEDGE REMS document (February 2026)
• Accutane (isotretinoin) prescribing information and Medication Guide, DailyMed
• MedlinePlus, Isotretinoin